Rifampicin-induced fever in a patient with brucellosis: A case report

We present a 35-year-old female patient who was started on rifampicin (900 mg orally once daily) and trimethoprim/sulfamethoxazole (TMP/SMX) (160/800 mg orally twice daily) after being diagnosed with brucellosis. Following defervescence and improvement in her general condition, fever recurred on the 12th day of treatment. A re-challenge drug test lead to causality assessment and treatment was switched to a combination of streptomycin (1 g intramuscularly) for 10 days and TMP/SMX (160/800 mg orally twice daily) for 4 weeks. Our patient is doing well after 12 months of follow-up.

Keywords

Brucellosis , Rifampicin-Induced Fever

Journal or Series

Drug Safety - Case Reports

Volume

5

Citation

Yılmaz, M., Yaşar, C., Aydın, S., Derin, O., Ceylan, B. ve Mert, A. (2018). Rifampicin-induced fever in a patient with brucellosis: A case report. Drug Safety - Case Reports, 5. https://dx.doi.org/10.1007/s40800-018-0074-3

URI

https://dx.doi.org/10.1007/s40800-018-0074-3
https://hdl.handle.net/20.500.12511/6404

Collections

Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu

Creative Commons license

Except where otherwise noted, this item's license is described as Attribution-NonCommercial 4.0 International

Full item page

Rifampicin-induced fever in a patient with brucellosis: A case report

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Access Rights

DOI

Abstract

Description

Keywords

Journal or Series

WoS Q Value

Scopus Q Value

Volume

Issue

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license